LANTERN PHARMA INC (LTRN) Stock Balance Sheet
NASDAQ:LTRN - Nasdaq - US51654W1018 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 7.51M | 21.94M | 37.20M | 51.52M | 19.23M | |||
| Marketable Securities | 16.50M | 19.36M | 17.99M | 19.20M | N/A | |||
| Other Current Assets | 1.23M | 2.04M | 3.53M | 1.99M | 1.01M | |||
| Total Current Assets | 25.25M | 43.34M | 58.72M | 72.72M | 20.24M | |||
| Non-Current Assets | ||||||||
| PPE Net | 287.40K | 280.40K | 100.00K | 220.00K | 20.00K | |||
| Other Non-Current Assets | 36.70K | 25.90K | 20.00K | 1.02M | 100.00K | |||
| Total Non-Current Assets | 324.20K | 306.30K | 120.00K | 1.23M | 120.00K | |||
| TOTAL ASSETS | 25.57M | 43.65M | 58.84M | 73.95M | 20.36M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 190.80K | 173.00K | 50.00K | 150.00K | N/A | |||
| Accounts Payable | 4.14M | 2.51M | 2.75M | 2.17M | 550.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 4.33M | 2.68M | 2.80M | 2.33M | 550.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 110.00K | |||
| Other Non-Current Liabilities | 52.80K | 61.50K | 0.00 | 50.00K | N/A | |||
| Total Non-Current Liabilities | 52.80K | 61.50K | 0.00 | 50.00K | 110.00K | |||
| TOTAL LIABILITIES | 4.38M | 2.74M | 2.80M | 2.38M | 660.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -76.03M | -55.24M | -39.28M | -25.02M | -12.66M | |||
| Additional Paid In Capital | 97.06M | 96.26M | 95.69M | 96.69M | 32.36M | |||
| Common Shares | 1.10K | 1.10K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 154.00K | -107.50K | -370.00K | -90.00K | N/A | |||
| Shares Outstanding | 10.78M | 10.72M | 10.86M | 11.09M | 6.22M | |||
| Tangible Book Value per Share | 1.96 | 3.82 | 5.16 | 6.45 | 3.17 | |||
| Total Shareholders' Equity | 21.19M | 40.91M | 56.04M | 71.57M | 19.70M | |||
| TOTAL LIABILITIES AND EQUITY | 25.57M | 43.65M | 58.84M | 73.95M | 20.36M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.01 | |||
| Current Ratio | 5.83 | 16.18 | 20.97 | 31.21 | 36.80 | |||
| Return On Assets (ROA) | -81.27% | -36.57% | -24.24% | -16.71% | -29.03% | |||
| Return On Equity (ROE) | -98.08% | -39.02% | -25.45% | -17.27% | -30.00% | |||
All data in USD , ROIC based on taxRate of 0.21